Aaptamine, a spongean alkaloid, activates p21 promoter in a p53-independent manner

Biochemical and Biophysical Research Communications

Volumn 342, Issue 1, 2006, Pages 101-106

  Aoki, Shunji ^a   Kong, Dexin ^a   Suna, Hideaki ^a   Sowa, Yoshihiro ^b   Sakai, Toshiyuki ^b   Setiawan, Andi ^c   Kobayashi, Motomasa ^a  

^a OSAKA UNIVERSITY   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c UNIVERSITY OF LAMPUNG   (Indonesia)

Author keywords

Aaptamine; G2 M arrest; MG63 cells; p21 promoter; Sp1 sites

Indexed keywords

AAPTAMINE; ANTINEOPLASTIC AGENT; MESSENGER RNA; PROTEIN P21; PROTEIN P53; TRANSCRIPTION FACTOR SP1;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOASSAY; CANCER CELL CULTURE; CELL CYCLE G2 PHASE; CELL STRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INDUCTION; GENE DELETION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SPONGE (PORIFERA); UPREGULATION; WILD TYPE;

ANIMALS; CELL CYCLE; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE DELETION; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; MOLECULAR STRUCTURE; MUTATION; NAPHTHYRIDINES; PORIFERA; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53;

PORIFERA;

EID: 32644462594     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.01.119     Document Type: Article

References (24)

1. W.S. El-Deiry, T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler, and B. Vogelstein WAF1, a potential mediator of p53 tumor suppression Cell 75 1993 817 825
2. J.W. Harper, G.R. Adami, N. Wei, K. Keyomarsi, and S.J. Elledge The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases Cell 75 1993 805 816
3. M. Hollstein, D. Sidransky, B. Vogelstein, and C.C. Harris P53 mutations in human cancers Science 253 1991 49 53
4. B. Vogelstein, and K.W. Kinzler P53 function and dysfunction Cell 70 1992 523 526
5. M. Chedid, P. Michieli, C. Lengel, K. Huppi, and D. Givol A single nucleotide substitution at codon 31 (Ser/Arg) defines a polymorphism in a highly conserved region of the p53-inducible gene WAF1/CIP1 Oncogene 9 1994 3021 3024
6. Y.J. Li, P. Laurent-Puig, R.J. Salmon, G. Thomas, and R. Hamelin Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer Oncogene 10 1995 599 601
7. K. Nakano, T. Mizuno, Y. Sowa, T. Orita, T. Yoshino, Y. Okuyama, T. Fujita, N. Ohtani-Fujita, Y. Matsukawa, T. Tokino, H. Yamagishi, T. Oka, H. Nomura, and T. Sakai Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line J. Biol. Chem. 272 1997 22199 22206
8. S. Aoki, K. Matsui, T. Takata, H. Wei, and M. Kobayashi Lembehyne A, a spongean polyacetylene, induces neuronal differentiation in neuroblastoma cell Biochem. Biophys. Res. Commun. 289 2001 558 563
9. S. Aoki, K. Matsui, T. Takata, and M. Kobayashi In situ photoaffinity labeling of the target protein for lembehyne A, a neuronal differentiation inducer FEBS Lett. 544 2003 223 227
10. S. Aoki, D. Kong, K. Matsui, and M. Kobayashi Smenospongine, a spongean sesquiterpene aminoquinone, induces erythroid differentiation in K562 cells Anti-Cancer Drugs 15 2004 363 369
11. S. Aoki, D. Kong, K. Matsui, R. Rachmat, and M. Kobayashi Sesquiterpene aminoquinones, from a marine sponge, induce erythroid differentiation in human chronic myelogenous leukemia, K562 cells Chem. Pharm. Bull. 52 2004 935 937
12. S. Aoki, D. Kong, K. Matsui, and M. Kobayashi Erythroid differentiation in K562 chronic myelogenous cells induced by crambescidin 800, a pentacyclic guanidine alkaloid Anticancer Res. 24 2004 2325 2330
13. Y. Sowa, T. Orita, S. Minamikawa, K. Nakano, T. Mizuno, H. Nomura, and T. Sakai Histone deacetylase inhibitor activates the WAF1/CIP1 gene promoter through the Sp1 sites Biochem. Biophys. Res. Commun. 241 1997 142 150
14. H. Nakamura, J. Kobayashi, and Y. Ohizumi Isolation and structure of aaptamine, a novel heteroaromatic substance possessing α-blocking activity from the sea sponge Aaptos aaptos Tetrahedron Lett. 23 1982 5555 5558
15. (WAF1/CIP1) gene Exp. Cell Res. 246 1999 280 289
16. C.J. Sherr Cancer cell cycles Science 274 1996 1672 1677
17. T. Owa, H. Yoshino, K. Yoshimatsu, and T. Nagasu Cell cycle regulation in the G1 phase: a promising target for the development of new chemotherapeutic anticancer agents Curr. Med. Chem. 8 2001 1487 1503
18. J. Lukas, D. Parry, L. Aagaard, D.J. Mann, J. Bartkova, M. Strauss, G. Peters, and J. Bartek Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16 Nature 375 1995 503 506
19. K. Nakayama, and K. Nakayama Cip/Kip cyclin-dependent kinase inhibitors: brakes of the cell cycle engine during development BioEssays 20 1998 1020 1029
20. F. Bunz, A. Dutriaux, C. Lengauer, T. Waldman, S. Zhou, J.P. Brown, J.M. Sedivy, K.W. Kinzler, and B. Vogelstein Requirement for p53 and p21 to sustain G2 arrest after DNA damage Science 282 1998 1497 1501
21. Y.H. Choi, W.H. Lee, K.Y. Park, and L. Zhang p53-Independent induction of p21(WAF1/CIP1), reduction of Cyclin B1 and G2/M arrest by the isoflavone Genistein in human prostate carcinoma cells Jpn. J. Cancer Res. 91 2000 164 173
22. 2 cell cycle arrest induced by Actinobacillus actinomycetemcomitans cytolethal distending toxin Infect. Immun. 70 2002 528 534
23. J.R. Biggs, J.E. Kudlow, and A.S. Kraft The role of the transcription factor Sp1 in regulating the expression of the WAF1/CIP1 gene in U937 leukemia cells J. Biol. Chem. 271 1996 901 906
24. WAF1/CIP1 in human prostate carcinoma cells J. Biol. Chem. 273 1998 10618 10623